Sponsored by: GE Healthcare

Molecular Imaging: Page 61

DOPA-PET can alter brain tumor therapy decisions
By Wayne Forrest
The use of the radiopharmaceutical fluorine-18 dihydroxyphenylalanine (F-18 DOPA) with PET imaging can lead to beneficial changes in management plans for patients with brain tumors, according to a study presented by French researchers at the recent Society of Nuclear Medicine and Molecular Imaging meeting.
July 10, 2017
2017 07 11 10 22 25 390 French Flag 400
PET agent could advance blood clot imaging
By AuntMinnieEurope.com staff writers
German researchers are developing an imaging method that uses a ligand labeled with F-18 to target glycoprotein IIb/IIIa receptors, potentially improving the visualization of blood clots in veins and arteries, according to a preclinical study published in the July issue of the Journal of Nuclear Medicine.
July 6, 2017
2017 07 07 13 30 25 86 Jnm Blood Clot Image 20170707203054
Motion compensation improves cardiac PET
By Tami Freeman, PhD
Cardiac PET is used to measure tissue viability, myocardial perfusion, and functional parameters such as ejection fraction (EF). The EF provides valuable information for patients with heart disease. Now, researchers have developed a method to compensate for respiratory motion.
July 2, 2017
2017 06 30 11 29 03 428 2017 07 03 Medphysweb Thumb
Yves Menu gets set to ride high at European Radiology
By Frances Rylands-Monk
The European Society of Radiology this week unveiled Dr. Yves Menu as the new editor in chief of its journal European Radiology. He will take over from Dr. Maximilian Reiser later this year and serve a three-year term.
June 25, 2017
2017 06 26 09 16 13 725 2017 06 26 Menu Motorbike Thumb
Hybrid multiplexing simplifies SiPM-based PET
By Jude Dineley
A hybrid multiplexing technique can help to facilitate an improved PET scanner based on silicon photomultipliers (SiPMs), according to researchers. Now they plan to begin work to incorporate the technique into an investigative, clinical-scale PET machine.
June 25, 2017
2017 06 23 11 30 02 43 2016 06 26 Medphysweb Thumb
German team wins SNMMI Image of the Year award
By Wayne Forrest
The U.S. Society of Nuclear Medicine and Molecular Imaging (SNMMI) on 14 June awarded its Image of the Year to German researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.
June 18, 2017
2017 06 14 11 04 16 259 Snmmi 2017 Image Of The Year 2017 20170614180516
SNMMI Image of the Year awarded to German researchers
By Wayne Forrest
DENVER - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) on Wednesday awarded its Image of the Year to researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.
June 18, 2017
2017 06 14 11 04 16 259 Snmmi 2017 Image Of The Year 2017 20170614180516
U.K. releases DRLs for hybrid imaging
By Rebekah Moan
A new U.K.-wide survey of radiation dose administered in a broad range of PET/CT and SPECT/CT imaging procedures has resulted in diagnostic reference levels (DRLs) for six common examinations, including cardiac and bone SPECT/CT.
June 15, 2017
2016 08 30 09 29 44 134 Radiation Symbol Circle 400
SNMMI: FET-PET could have answers for brainstem glioma
By Wayne Forrest
Researchers in Switzerland are setting their sights on fluoroethyl-tyrosine (FET) PET imaging as the best way to assess adult brainstem glioma and gauge patients' chances for progression-free survival. Study results were presented on 11 June at the U.S. Society of Nuclear Medicine and Molecular Imaging annual meeting in Denver, Colorado.
June 13, 2017
2017 06 13 11 44 38 458 2017 06 14 Snmmi Thumb
PET/optical combo can guide breast-conserving surgery
By Wayne Forrest
Researchers are reporting early success in the combination of optical and molecular imaging to view FDG-PET images that detect early-stage breast cancer. The technique can assess tumor margins during breast tumor surgery by detecting light emitted from an FDG-PET radiopharmaceutical.
June 11, 2017
2017 06 08 11 20 43 43 2017 06 12 Cli Image Jnm Thumb
Blue Earth secures marketing authorization for Axumin
By AuntMinnieEurope.com staff writers
Molecular imaging diagnostics firm Blue Earth Diagnostics has received marketing authorization from the European Commission for its Axumin (fluciclovine F-18) PET agent.
May 22, 2017
AuntMinnieEurope.com Molecular Imaging Insider
By Wayne Forrest
May 17, 2017
Previous Page
Page 61 of 122
Next Page